Download image:

Eric Johnson

Senior Fellow, Senior Research Scientist

Eric Johnson, PhD, has more than 18 years of experience bridging the fields of social and genetic epidemiology: examining mental, substance use, and sleep disorders, as well as HIV. He has authored more than 75 peer-reviewed journal articles on these areas of research.

Dr. Johnson is currently leading several major studies regarding HIV and substance use focused on gene discovery, gene by environment interactions, and epigenetics. These studies are helping researchers identify genetic variants and potential molecular mechanisms underlying risks associated with developing these conditions. With this information, Dr. Johnson and his colleagues hope to identify new targets for medication development and better target therapies for HIV or substance dependencies to individual patient's needs. Previously, he led a sleep disorder study that found insomnia was common among teens and may lead to psychiatric disorders.

He now serves as the chair of the Behavioral Genetics and Epidemiology Study Section in the Center for Scientific Review at the National Institutes of Health (NIH). Dr. Johnson has served on numerous other review and expert panels across the NIH.


Postdoctoral fellowships in epidemiology (Johns Hopkins University) and genetics (National Institute on Drug Abuse); PhD, Sociology, Western Michigan University; MA, Sociology, Western Michigan University; BA, Sociology and Psychology, Olivet Nazarene University.

Latest Publications

Xie, Y., Hancock, D.B., Johnson, E.O., & Rice, J.P. (2014). Two adjustment strategies for imputation across genotyping arrays. Human Heredity, 78 (2):73-80.
Culverhouse, R.C., Johnson, E.O., Breslau, N., Hatsukami, D.K., Sadler, B., Brooks, A.I., et al. (2014). Multiple distinct CHRNB3-CHRNA6 variants are genetic risk factors for nicotine dependence in African Americans and European Americans. Addiction, 109 (5):814-822.
Sadler, B., Haller, G., Agrawal, A., Culverhouse, R., Bucholz, K., Brooks, A., Tischfield, J., Johnson, E.O., et al. (2014). Variants near CHRNB3-CHRNA6 are associated with DSM-5 cocaine use disorder: Evidence for pleiotropy. Sci Rep , 4 :Article No. 4497.
Bierut, L.J., Johnson, E.O., & Saccone, N.L. (2014). A glimpse into the future – Personalized medicine for smoking cessation. Neuropharmacology, 76 (Part B):592-599.
Agrawal, A., Lynskey, M.T., Bucholz, K.K., Kapoor, M., Almasy, L., Dick, D.M., Edenberg, H.J., Foroud, T., Goate, A., Hancock, D.B., Hartz, S., Johnson, E.O., et al. (2014). DSM-5 cannabis use disorder: A phenotypic and genomic perspective. Drug and Alcohol Dependence, 134 :362-369.
View all publications by Eric Johnson (76)